Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Avecris logo — Avecris is developing non-viral gene delivery technologies w...

Avecris

Avecris is developing non-viral gene delivery technologies with unprecedented activity and specificity

Founded 2022 Singapore Singapore 6 employees Grant Total: $3.61M Life Sciences

General Information

Company Name Avecris
Founded Year 2022
Location Singapore Singapore
Employees 6
Industries Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Avecris. To contact Avecris, visit avecris.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Avecris

Avecris is a Singapore-based startup founded in 2017, focusing on developing non-viral gene delivery technologies. The company's slogan "Avecris is developing non-viral gene delivery technologies with unprecedented activity and specificity" underscores its commitment to innovation. Avecris's novel genetic vector platform technology is universally programmable, scalable, redosable, non-integrating, cell-type specific, and low cost, positioning it towards a new class of medicines. The company's recent last investment of $5.00K came through a grant investment on 10 August 2022, with First Flight Venture Center as the investors. With its promising technology and strategic location, Avecris is poised to make a significant impact in the biotech industry.

Taxonomy: genetic vector platform technology, mRNA / RNA approaches, cell-type specific gene expression, protein expression, mitochondrial gene therapy, non-viral gene delivery, scalable manufacturing, low-cost, gene therapy, innovation, biomedical technology, mitochondrial disorders, pharmaceutical research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $5.00K 1
First Flight Venture Center
First Flight Venture Center
10 Aug 2022
Venture Round $3.60M 1
Alameda Research
01 Jan 2022

Avecris Alternatives & Competitors

View All Alternatives
Avecris vs
Gennao Bio
Gennao Bio United States

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

Series A
5 employees
Biotechnology, Health Care
Avecris vs
Basilard BioTech, Inc.
Basilard BioTech, Inc. United States

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology
Avecris vs
Strand Therapeutics
Strand Therapeutics United States

Where synthetic biology meets RNA therapeutics

Series A
121 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Avecris

Avecris is developing non-viral gene delivery technologies with unprecedented activity and specificity
Avecris was founded in 2022.
Avecris is headquartered in Singapore.
Avecris operates in Life Sciences. Its work centres on genetic vector platform technology, mRNA / RNA approaches, cell-type specific gene expression and protein expression.
Avecris has approximately 6 employees.
Avecris has completed 2 funding rounds, raising a total of $3.61M. The latest funding stage is Grant.
Top alternatives and competitors to Avecris include Gennao Bio, Basilard BioTech, Inc., Strand Therapeutics, Code Biotherapeutics, ProBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avecris and Gennao Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avecris, https://bouncewatch.com/company/avecris, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes